logo
Vol. 6 Núm. 10 (2008)
Publicado 2008-12-15
Licencia
Artículo de Revisión

Oxidative stress-induced mitochondrial failure and vasoactive substances as key initiators of pathology favor the reclassification of Alzheimer Disease as a vasocognopathy

DOI: https://doi.org/10.22490/24629448.408
Gjumrakch Aliev Department of Nutrition and Biochemistry, Javeriana University, Bogota, Colombia. Department of Biology, and Electron Microscopy Research Center, College of Sciences, University of Texas
Joséph Charles Lamanna Department of Anatomy, Case Western Reserve University.
Ludis Morales Álvarez Department of Nutrition and Biochemistry, Javeriana University, Bogota, Colombia
Mark Eric Obrenovich Department of Pathology, Case Western Reserve University
Gerardo Jesús Pacheco Department of Biology, and Electron Microscopy Research Center, College of Sciences, University of Texas
Hector Palacios Department of Biology, and Electron Microscopy Research Center, College of Sciences, University of Texas
Eldar Qasimov Department of Cytology, Histology & Embryology, Azerbaijan Medical University, Baku Azerbaijan
Brianna Walrafen Department of Biology, and Electron Microscopy Research Center, College of Sciences, University of Texas
PDF
Alzheimer disease and cerebrovascular accident are two leading causes of age-related dementia. Increasing evidence supports the idea that chronic hypoperfusion is primarily responsible for the pathogenesis that underlies both disease processes. Hypoperfusion is associated with oxidative imbalance, largely due to reactive oxygen species, which is associated with other age-related degenerative disorders. Recent evidence indicates that a chronic injury stimulus induces the hypoperfusion seen in the microcirculation of vulnerable regions of the brain. This leads to energy failure, manifested by damaged mitochondrial ultrastructure. Mitochondrial derangements lead to the formation of a large number of electron-dense, ¿hypoxic¿ mitochondria and cause the overproduction of mitochondrial DNA (mtDNA) deletions, which is most likely due to double stranded breaks. Additionally, these mitochondrial abnormalities coexist with increased redox metal activity, lipid peroxidation, and RNA oxidation, all of which are well established features of Alzheimer disease pathology, prior to the appearance of amyloid b deposition. Alzheimer disease, oxidative stress occurs within various cellular compartments and within certain cell types more than others, namely the vascular endothelium, which is associated with atherosclerotic damage, as well as in pyramidal neurons and glia. Interestingly, these vulnerable cells show mtDNA deletions and oxidative stress markers only in the regions that are closely associated with damaged vessels. This evidence strongly suggests that chronic hypoperfusion induces the accumulation of the oxidative stress products. Furthermore, brain vascular wall lesions linearly correlate with the degree of neuronal and glial cell damage. We, therefore, conclude that chronic hypoperfusion is a key initiator of oxidative stress in various brain parenchymal cells, and the mitochondria appear to be primary targets for brain damage in Alzheimer disease. In this manuscript, we outline a role for the continuous accumulation of oxidative stress products, such as an abundance of nitric oxide products (via the overexpression of inducible and/or neuronal NO synthase (iNOS and nNOS respectively) and peroxynitrite accumulation, as secondary but accelerating factors compromising the blood brain barrier (BBB). If this turns out to be the case, pharmacological interventions that target chronic hypoperfusion might ameliorate the key features of dementing neurodegeneration.
Palabras clave: brain hypoperfusion, mitochondria, neurodegeneration, nitric oxide, oxidation, oxidative stress, vasoactive substances.
Licencia
Cómo citar
Aliev, G., Lamanna, J. C., Morales Álvarez, L., Obrenovich, M. E., Pacheco, G. J., Palacios, H., Qasimov, E., & Walrafen, B. (2008). Oxidative stress-induced mitochondrial failure and vasoactive substances as key initiators of pathology favor the reclassification of Alzheimer Disease as a vasocognopathy. Revista Nova publicación científica En Ciencias biomédicas, 6(10), 170-189. https://doi.org/10.22490/24629448.408
Almétricas
Métricas
Archivos descargados
206
Jan 2009Jul 2009Jan 2010Jul 2010Jan 2011Jul 2011Jan 2012Jul 2012Jan 2013Jul 2013Jan 2014Jul 2014Jan 2015Jul 2015Jan 2016Jul 2016Jan 2017Jul 2017Jan 2018Jul 2018Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 20269
|

DECLARACIÓN DE PRIVACIDAD: Según la Ley de Protección de Datos Personales (Ley 1581 de 2012), los nombres y direcciones de correo electrónico manejados por Revista NOVA se usarán exclusivamente para los fines declarados por esta revista y no estarán disponibles para ningún otro propósito u otra persona. Los manuscritos enviados a la publicación solo son conocidos por el equipo editorial y por los pares evaluadores externos.

Diseño e implementado por